Home / mesothelioma / mesothelioma law firm / Novartis melanoma drug combination wins EU green light

Friday, July 24, 2015

Novartis melanoma drug combination wins EU green light

By Unknown
On

ReutersNovartis melanoma drug combination wins EU green lightReutersLONDON European regulators on Friday recommended the use of a combination of Novartis's drugs Tafinlar and Mekinist for treating certain patients with melanoma, boosting prospects for medicines acquired from GlaxoSmithKline. The Swiss drugmaker ...and more »

Novartis melanoma drug combination wins EU green light Rating: 4.5 Diposkan Oleh: Unknown

Subscribe to: Post Comments (Atom)
 

Top